2026-01-29
SI investment contract between JW pharmaceutical and S&E bio
본문
JW Pharmaceutical (중외제약) announced on the 17th of Nov 2022 that it has signed a strategic investment (SI) contract with S&E bio to strengthen its open innovation strategy (open innovation). The detailed news can be found at the link below.
- 이전글Our department's name has been changed. 26.01.29
- 다음글A new research article has been published!!! 26.01.29
댓글목록
등록된 댓글이 없습니다.